| __timestamp | Regeneron Pharmaceuticals, Inc. | Teva Pharmaceutical Industries Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 205018000 | 9216000000 |
| Thursday, January 1, 2015 | 392709000 | 8296000000 |
| Friday, January 1, 2016 | 299694000 | 10044000000 |
| Sunday, January 1, 2017 | 397061000 | 11560000000 |
| Monday, January 1, 2018 | 434100000 | 10558000000 |
| Tuesday, January 1, 2019 | 782200000 | 9351000000 |
| Wednesday, January 1, 2020 | 1119900000 | 8933000000 |
| Friday, January 1, 2021 | 2437500000 | 8284000000 |
| Saturday, January 1, 2022 | 1560400000 | 7952000000 |
| Sunday, January 1, 2023 | 1815800000 | 8200000000 |
| Monday, January 1, 2024 | 1970500000 | 8480000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. From 2014 to 2023, Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited have shown contrasting trends in their cost of revenue. Regeneron has seen a remarkable increase, with costs rising by approximately 785% over the decade, peaking in 2021. This surge reflects their aggressive expansion and investment in innovative therapies. In contrast, Teva's cost of revenue has decreased by about 14% during the same period, indicating a strategic shift towards cost efficiency and possibly restructuring efforts.
These trends highlight the differing strategies of these pharmaceutical giants. Regeneron's focus on growth and innovation contrasts with Teva's emphasis on streamlining operations. As the industry faces challenges like patent cliffs and regulatory changes, these insights provide a window into how companies adapt to maintain competitiveness.
Cost Insights: Breaking Down Amgen Inc. and Regeneron Pharmaceuticals, Inc.'s Expenses
Cost Insights: Breaking Down Amgen Inc. and Teva Pharmaceutical Industries Limited's Expenses
Comparing Cost of Revenue Efficiency: Gilead Sciences, Inc. vs Teva Pharmaceutical Industries Limited
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs Walgreens Boots Alliance, Inc.
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Corcept Therapeutics Incorporated's Expenses
Cost of Revenue Trends: Regeneron Pharmaceuticals, Inc. vs Alkermes plc
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs MorphoSys AG
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Evotec SE's Expenses
Cost of Revenue Trends: Teva Pharmaceutical Industries Limited vs Ionis Pharmaceuticals, Inc.
Cost of Revenue: Key Insights for Teva Pharmaceutical Industries Limited and ADMA Biologics, Inc.
Cost of Revenue Comparison: Teva Pharmaceutical Industries Limited vs Xenon Pharmaceuticals Inc.
Cost Insights: Breaking Down Teva Pharmaceutical Industries Limited and Viridian Therapeutics, Inc.'s Expenses